Baird Medical Sponsored and Showcased Advanced Microwave Ablation (MWA) Technology at the Sichuan Medical Association Thyroid Disease Conference
Baird Medical (NASDAQ: BDMD), a leader in minimally invasive microwave ablation (MWA) technology, sponsored and participated in the 4th Sichuan Medical Association Thyroid Disease Academic Conference in China. The company showcased its advanced MWA technology for thyroid nodules, featuring larger ablation zones and shorter treatment times.
During the conference, which brought together prominent thyroid specialists and healthcare professionals, Baird Medical engaged in discussions with medical leaders and presented its innovative solutions. Chairwoman Haimei Wu emphasized the company's commitment to advancing thyroid disease treatment and improving patient outcomes through technological innovation and professional collaboration.
Baird Medical (NASDAQ: BDMD), un leader nella tecnologia di ablazione a microonde minimamente invasiva (MWA), ha sponsorizzato e partecipato alla 4ª Conferenza Accademica sulla Malattia della Tiroide dell'Associazione Medica del Sichuan in Cina. L'azienda ha presentato la sua avanzata tecnologia MWA per i noduli tiroidei, caratterizzata da aree di ablazione più ampie e tempi di trattamento più brevi.
Durante la conferenza, che ha riunito i principali specialisti della tiroide e professionisti della salute, Baird Medical ha avviato discussioni con leader medici e ha presentato le sue soluzioni innovative. La presidente Haimei Wu ha sottolineato l'impegno dell'azienda per il progresso nel trattamento delle malattie tiroidee e il miglioramento dei risultati per i pazienti attraverso l'innovazione tecnologica e la collaborazione professionale.
Baird Medical (NASDAQ: BDMD), un líder en tecnología de ablación por microondas mínimamente invasiva (MWA), patrocinó y participó en la 4ª Conferencia Académica sobre Enfermedades de la Tiroides de la Asociación Médica de Sichuan en China. La empresa mostró su avanzada tecnología MWA para nódulos tiroideos, con zonas de ablación más grandes y tiempos de tratamiento más cortos.
Durante la conferencia, que reunió a destacados especialistas en tiroides y profesionales de la salud, Baird Medical participó en discusiones con líderes médicos y presentó sus soluciones innovadoras. La presidenta Haimei Wu enfatizó el compromiso de la empresa con el avance en el tratamiento de enfermedades tiroideas y la mejora de los resultados para los pacientes a través de la innovación tecnológica y la colaboración profesional.
Baird Medical (NASDAQ: BDMD), 최소 침습 마이크로웨이브 절제술(MWA) 기술의 선두주자가, 중국에서 열린 제4회 사천의학회 갑상선 질환 학술 회의에 후원하고 참여했습니다. 이 회사는 갑상선 결절을 위한 최신 MWA 기술을 선보였으며, 더 큰 절제 영역과 짧은 치료 시간을 자랑했습니다.
이 회의에는 저명한 갑상선 전문가와 의료 전문가들이 모였으며, Baird Medical은 의료 리더들과 활발한 논의를 진행하고 혁신적인 솔루션을 발표했습니다. 회장 Haimei Wu는 기술 혁신과 전문적인 협력을 통해 갑상선 질환 치료의 발전과 환자 결과 개선에 대한 회사의 헌신을 강조했습니다.
Baird Medical (NASDAQ: BDMD), un leader dans la technologie d'ablation par micro-ondes minimalement invasive (MWA), a parrainé et participé à la 4ème Conférence académique de l'Association médicale du Sichuan sur les maladies de la thyroïde en Chine. L'entreprise a présenté sa technologie MWA avancée pour les nœuds thyroïdiens, offrant des zones d'ablation plus larges et des temps de traitement plus courts.
Lors de la conférence, qui a réuni des spécialistes de la thyroïde et des professionnels de la santé de premier plan, Baird Medical a engagé des discussions avec des leaders médicaux et a présenté ses solutions innovantes. La présidente Haimei Wu a souligné l'engagement de l'entreprise à faire progresser le traitement des maladies de la thyroïde et à améliorer les résultats pour les patients grâce à l'innovation technologique et à la collaboration professionnelle.
Baird Medical (NASDAQ: BDMD), ein führendes Unternehmen im Bereich der minimal invasiven Mikrowellen-Ablationstechnik (MWA), sponserte und nahm an der 4. Akademischen Konferenz zur Schilddrüsenerkrankung der Sichuan Medical Association in China teil. Das Unternehmen stellte seine fortschrittliche MWA-Technologie für Schilddrüsenknoten vor, die größere Ablationszonen und kürzere Behandlungszeiten aufweist.
Während der Konferenz, die bedeutende Schilddrüsenspezialisten und Gesundheitsfachkräfte zusammenbrachte, führte Baird Medical Gespräche mit medizinischen Führungspersönlichkeiten und präsentierte seine innovativen Lösungen. Die Vorsitzende Haimei Wu betonte das Engagement des Unternehmens, die Behandlung von Schilddrüsenerkrankungen voranzutreiben und die Patientenergebnisse durch technologische Innovation und professionelle Zusammenarbeit zu verbessern.
- Successfully showcased advanced MWA technology with improved features (larger ablation zones, shorter treatment times)
- Strengthened market presence in China's healthcare sector through conference sponsorship
- None.
The highly regarded conference gathered top thyroid specialists and healthcare professionals to promote best practices in thyroid disease diagnosis and treatment. Baird Medical's sponsorship underscored its commitment to advancing medical innovation and fostering academic collaboration in
During the event, Baird Medical presented its state-of-the-art MWA technology for thyroid nodules. The innovative solution, designed to deliver larger ablation zones and shorter treatment times, attracted significant attention for its potential to improve patient outcomes and set new standards for minimally invasive care. The company also engaged in high-level discussions with medical leaders, further solidifying its position as a key player in the global healthcare market.
"Our participation in this prominent conference reflected Baird Medical's commitment to supporting advancements in thyroid disease treatment," said Haimei Wu, Chairwoman of Baird Medical. "By presenting our latest MWA technology, we contributed to the ongoing dialogue on improving treatment options and patient outcomes. We remain dedicated to collaborating with medical professionals to promote innovation and enhance care standards globally."
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.
These forward-looking statements are subject to risks, uncertainties, and assumptions that could cause actual results or outcomes to differ materially from those expressed or implied. These statements are based on estimates and assumptions that, while considered reasonable by Baird Medical and its management, are inherently uncertain. Risks and uncertainties may emerge over time, and it is not possible to anticipate all potential factors that could affect Baird Medical's business and financial performance.
Factors that could cause actual results to differ materially include, but are not limited to: (1) the risk that Baird Medical may not achieve its expansion goals in
Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. Baird Medical undertakes no obligation to update or revise forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All forward-looking statements in this press release are qualified in their entirety by this cautionary statement.
View original content to download multimedia:https://www.prnewswire.com/news-releases/baird-medical-sponsored-and-showcased-advanced-microwave-ablation-mwa-technology-at-the-sichuan-medical-association-thyroid-disease-conference-302342737.html
SOURCE BDMD
FAQ
What new MWA technology features did Baird Medical (BDMD) present at the Sichuan conference?
How is Baird Medical (BDMD) expanding its presence in the Chinese healthcare market?
What are the key benefits of Baird Medical's (BDMD) new MWA technology for patients?
What was the significance of BDMD's participation in the Sichuan Medical Association conference?
